Recursion Pharmaceuticals has patented a method for molecular scaffold hopping, involving sending instructions from a scheduler computer to a job runner computer to perform computational tasks on chemical properties. The system includes preemptible computing instances and resends instructions for failed tasks to increase fault-tolerance. GlobalData’s report on Recursion Pharmaceuticals gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Recursion Pharmaceuticals Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Recursion Pharmaceuticals, Vehicle driver physiological monitoring was a key innovation area identified from patents. Recursion Pharmaceuticals's grant share as of May 2024 was 14%. Grant share is based on the ratio of number of grants to total number of patents.

Method of molecular scaffold hopping using preemptible computing instances

Source: United States Patent and Trademark Office (USPTO). Credit: Recursion Pharmaceuticals Inc

A recently granted patent (Publication Number: US12014804B2) discloses a method and apparatus for molecular scaffold hopping. The method involves sending instructions from a scheduler computer to a job runner computer to perform computational tasks related to calculating chemical properties for molecules. These tasks include calculating molecular fingerprint differences and similarity scores, with the ability to resend instructions for failed tasks to increase fault-tolerance. The apparatus includes a scheduler computer with a processor and interface to manage the computational tasks and resend instructions as needed, enhancing the efficiency of the molecular scaffold hopping process.

Furthermore, the patent details the use of preemptible computing instances for the tasks, allowing for increased flexibility and fault-tolerance in case of failures. The method also includes features such as molecular weight filtering to select specific molecules for analysis and the ability to initiate tasks at different times. The non-transitory computer-readable storage media containing instructions for the method ensures consistency and accuracy in performing the molecular scaffold hopping process. Overall, the patent provides a comprehensive system for efficiently conducting molecular scaffold hopping, a crucial process in drug discovery and molecular research.

To know more about GlobalData’s detailed insights on Recursion Pharmaceuticals, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies